Sridhar Kosaraju, Director at 10x Genomics, Inc. (TXG), sold 2,100 shares at $166.60 ($349K) on 2021-10-25, disclosed to the SEC on 2021-10-27.
Open-market sale of $349k TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $163.85 | 100 | $16K | 4.7% |
| 2 | $165.14 | 600 | $99K | 28.4% |
| 3 | $165.14 | 600 | $99K | 28.4% |
| 4 | $166.60 | 400 | $67K | 19.1% |
| 5 | $167.63 | 100 | $17K | 4.8% |
| 6 | $168.68 | 300 |
| $51K |
| 14.5% |
| Total | $165.98 avg | 2,100 | $349K | 100% |
| Filing → |
| TXG | SELL | 2021-09-24 | $239K | — | Filing → |
| TXG | SELL | 2021-08-25 | $243K | — | Filing → |
| TXG | SELL | 2021-07-26 | $359K | — | Filing → |